Virus-like particles (VLPs) are recombined from viruses through genetic engineering technology. The VLP is safety without any infection factors. They can load different types of drugs and deliver them to specific target organs.
The potential of VLP for cancer and genetic defect treatment. he reports o indicate that able to deliver different types of therapeutic agents to specific organs through specifically surface protein recognition.
Our drug delivery system platform of VLP is able to carrytherapeutic agents such as small molecule drugs, proteins, RNA, or DNA to specific organs or cells thatprovide effectiveness for targeting therapy in cancer.